Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study

Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

(2016) Venkata K. Pokuri et al.   Clinical Genitourinary Cancer

Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis

(2016) Ahmed A. Hussein et al.   UROLOGY

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer

(2015) Matthew D. Galsky et al.   CANCER

A review of relative dose intensity and survival in patients with metastatic solid tumors

(2015) Laura J. Havrilesky et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium

(2015) Syed Johar Raza et al.   EUROPEAN UROLOGY

Systematic Review and Cumulative Analysis of Oncologic and Functional Outcomes After Robot-assisted Radical Cystectomy

(2015) Bertram Yuh et al.   EUROPEAN UROLOGY

Best Practices in Robot-assisted Radical Cystectomy and Urinary Reconstruction: Recommendations of the Pasadena Consensus Panel

(2015) Timothy G. Wilson et al.   EUROPEAN UROLOGY

The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review

(2014) Harman M. Bruins et al.   EUROPEAN UROLOGY

The Effect of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients Who Have Bladder Cancer Treated with Radical Cystectomy: A Population-based Study

(2014) Giorgio Gandaglia et al.   EUROPEAN UROLOGY

Complications After Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium

(2013) Raza S. Johar et al.   EUROPEAN UROLOGY

Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis

(2013) Fausto Petrelli et al.   EUROPEAN UROLOGY

Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients

(2012) Richard E. Hautmann et al.   EUROPEAN UROLOGY

Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study

(2011) Hassan Abol-Enein et al.   EUROPEAN UROLOGY

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer

(2011) Robert Rosenblatt et al.   EUROPEAN UROLOGY

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

(2011)   JOURNAL OF CLINICAL ONCOLOGY

BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

(2010) A. Font et al.   ANNALS OF ONCOLOGY

Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy

(2010) KYOUNG Ha KIM et al.   APMIS

Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer

(2010) Ganesh V. Raj et al.   CANCER